Xtract One arranges $10M bought deal offering

Executive Summary

• Xtract One Technologies Inc. has entered into a bought deal agreement with a syndicate of underwriters led by Stifel Canada to raise gross proceeds of $10 million.
• The company is issuing 13,334,000 units at a price of $0.75 per unit, with each unit comprising one common share and one-half of a common share purchase warrant.
• The net proceeds will be utilized for working capital and general corporate purposes, with the offering scheduled to close on or about November 10, 2025.

Key Details

• Transaction Structure: Bought deal offering led by Stifel Canada.
• Units Issued: 13,334,000 units.
• Price Per Unit: $0.75.
• Gross Proceeds: $10,000,500.
• Unit Composition: Each unit consists of one common share and one-half of one common share purchase warrant.
• Warrant Terms:
  • Exercise Price: $0.95 per common share.
  • Duration: Exercisable at any time up to 36 months following the closing date.
• Overallotment Option: Underwriters have an option to purchase up to an additional 2,000,100 units to cover overallotments and for market stabilization.
• Potential Gross Proceeds (with Overallotment): $11,500,575.
• Use of Proceeds: Working capital and general corporate purposes.
• Closing Date: On or about November 10, 2025.
• Regulatory Conditions: Subject to receipt of necessary approvals, including the Toronto Stock Exchange and securities regulatory authorities.
• Offering Mechanism: Offered by way of a shelf prospectus supplement pursuant to National Instrument 44-102 (Shelf Distributions).